Recruiting
Gastric cancer+3
RecruitingStudy of BOLD-100 with FOLFOX chemotherapy (fluorouracil, folinic acid, and oxaliplatin) in patients with advanced gastrointestinal tumors, colorectal, gastric, or pancreatic cancer
Registered drugNo placebo
Study of BOLD-100 with FOLFOX chemotherapy (fluorouracil, folinic acid, and oxaliplatin) in patients with advanced gastrointestinal tumors, colorectal, gastric, or pancreatic cancer
Registered drugNo placebo
- Disease:Gastric cancerColorectal cancer+2
- Substances:FluorouracilFolinic Acid+2
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Fluorouracil



